ICU Medical, Inc. to Present at the UBS Global Life Sciences Conference

| Source: ICU Medical, Inc.

SAN CLEMENTE, Calif., Sept. 5, 2012 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that Company management will be presenting at the UBS Global Life Sciences Conference to be held on September 19-20, 2012, at the Grand Hyatt Hotel, New York.

ICU Medical's presentation will take place on Wednesday, September 19, at 2:30 PM Eastern Time.

A copy of the slides to be presented may be found by going to the Company's website at, clicking on the Investors tab, clicking on Presentations and clicking on the September 2012 Investor Presentation.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections, protecting healthcare workers from exposure to infectious diseases or hazardous drugs and monitor continuous cardiac output of critical care patients. The Company's complete product line includes custom I.V. systems, closed delivery systems for hazardous drugs, needleless I.V. connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. For more information, visit the Company's website at" target="_top" rel="nofollow">

ICU Medical, Inc.
Scott Lamb, Chief Financial Officer
(949) 366-2183

John F. Mills, Senior Managing Director
(310) 954-1105